$DRTS

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (3d)

+19.4%

Win rate (3d)

100% (1 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 2, 4:30 PM ET

$DRTSr/wallstreetbetsDDbullish

u/passionlessDrone · 3h agono track record yet

Long 3,500 shares of DRTS

DRTS - Cancer Goes Bye Bye / Portfolio Goes High High

DRTS's radium-224 alpha-particle cancer therapy works on multiple solid tumor types regardless of genetic signature, offering superior outcomes compared to conventional oncology treatments. Early trial results show strong efficacy (100% local disease control in pancreatic, high complete response in glioblastoma, FDA breakthrough designation), with the author projecting significant value creation as regulatory and logistical challenges are solved.

Now $14.77as of Oct 2, 4:30 PM ET

original post →

$DRTSr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish

u/Pristine_Hurry_4693 · 299d agono track record yet

This should be the main news on CNBC today, don’t miss this play just because it’s under the radar! [DRTS]

Alpha Tau (DRTS) announced the first successful GBM patient treatment using its revolutionary solid tumor therapy, earning FDA Breakthrough Device Designation. With a ~$350M market cap, the company's proven efficacy across multiple cancer types and upcoming catalysts (PMDA approval in Japan) present a compelling risk/reward opportunity.

At post $4.23Now $14.77+249.2% since postedas of Oct 2, 4:30 PM ET

1d+19.6%

3d+19.4%

1w+21.5%

1m+51.5%

3m+58.6%

6m+121.0%

1y—

original post →

End of results.